| dc.contributor.author | Coban, A. Y. | |
| dc.contributor.author | Martin, A. | |
| dc.contributor.author | Uzun, M. | |
| dc.contributor.author | Bilgin, K. | |
| dc.contributor.author | Palomino, J. C. | |
| dc.contributor.author | Durupinar, B. | |
| dc.date.accessioned | 2020-06-21T15:13:44Z | |
| dc.date.available | 2020-06-21T15:13:44Z | |
| dc.date.issued | 2008 | |
| dc.identifier.issn | 1120-009X | |
| dc.identifier.issn | 1973-9478 | |
| dc.identifier.uri | https://doi.org/10.1179/joc.2008.20.3.388 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/19298 | |
| dc.description | WOS: 000257600000020 | en_US |
| dc.description | PubMed: 18606599 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Taylor & Francis Ltd | en_US |
| dc.relation.isversionof | 10.1179/joc.2008.20.3.388 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Evaluation of blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line antituberculous drugs: Results from two centers | en_US |
| dc.type | letter | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 20 | en_US |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.startpage | 388 | en_US |
| dc.identifier.endpage | 390 | en_US |
| dc.relation.journal | Journal of Chemotherapy | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
